• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
72,696.39 -1,836.57
( -2.46%)
Global Indices
Nasdaq
45,612.20 -430.24
(-0.93%)
Dow Jones
6,526.68 -100.81
(-1.52%)
Hang Seng
51,583.72 -1,788.81
(-3.35%)
Nikkei 225
9,927.54 -135.96
(-1.35%)
Forex
USD-INR
93.13 0.41
(0.44%)
EUR-INR
107.17 0.41
(0.39%)
GBP-INR
124.14 0.56
(0.45%)
JPY-INR
0.59 0.00
(0.73%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
62.6776943
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
58.44
2953.82
EPS(TTM)
Face Value()
Div & Yield %
5.04
1
0.03
 

kiocl ltd
AGI Greenpac approves acquisition of 19.75% stake in Madoverbuilding AI
Jan 29,2026
The board of AGI Greenpac at its meeting held on 28 January 2026 has approved the acquisition of 19.75% instead of 25% of the paid-up share capital of Madoverbuilding AI.

MOB AI is in the business of building E-commerce marketplace, E-commerce technologies, E-business platforms, embedding lending technologies, trading without and/ or with owned and/ or franchised stores, warehousing and rental capabilities for building, construction and interior materials and related items along with relevant logistic capabilities.

The Company has acquired 14.28% of the paid-up share capital of MOB AI (on fully diluted basis) on completion of Tranche 1 Investment dated 30th May 2025 and will hold an aggregate of 19.75% of the paid-up share capital of MOB AI (on fully diluted basis) on completion of Tranche 2 Investment.

The cost of acquisition is Rs 4.44 crore for both Tranch 1 and Tranch 2.